IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aviva Holdings Ltd.

Q2 2017 Holdings

Filed 2017-08-14 | 6 holdings | $129.0K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2018-02-14) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Medicines CoACOMMON584688105$102.8K2,703,48979.6%
Esperion Therapeutics Inc NE(ESPR)ACOMMON29664W105$15.7K340,10012.2%
Mirati Therapeutics Inc(MRTXEUR)ACOMMON60468T105$10.5K2,881,7028.2%